State Street SPDR S&P Biotech ETF (XBI)
NYSEARCA: XBI · Real-Time Price · USD
114.50
-0.68 (-0.59%)
Nov 19, 2025, 4:00 PM EST - Market closed

XBI Holdings Information

XBI is an equity ETF with a total of 135 individual holdings. The top holdings are Revolution Medicines stock at 2.54%, Avidity Biosciences at 2.46%, Insmed at 2.23%, Regeneron Pharmaceuticals at 2.11%, and Madrigal Pharmaceuticals at 2.10%.

Total Holdings
25
Top 10 Percentage
21.46%
Asset Class
Equity
ETF Category
Health
Assets
7.62B
PE Ratio
n/a

Sector Allocation

Top 25 Holdings

No.SymbolName WeightShares
1RVMDRevolution Medicines, Inc.2.54%2,704,392
2RNAAvidity Biosciences, Inc.2.46%2,608,850
3INSMInsmed Incorporated2.23%829,547
4REGNRegeneron Pharmaceuticals, Inc.2.11%217,801
5MDGLMadrigal Pharmaceuticals, Inc.2.10%281,425
6EXASExact Sciences Corporation2.05%2,210,197
7NTRANatera, Inc.2.03%712,982
8BBIOBridgeBio Pharma, Inc.2.00%2,285,749
9AMGNAmgen Inc.1.99%434,660
10INCYIncyte Corporation1.94%1,403,472
11UTHRUnited Therapeutics Corporation1.94%305,308
12ROIVRoivant Sciences Ltd.1.93%7,044,660
13BIIBBiogen Inc.1.91%848,825
14IONSIonis Pharmaceuticals, Inc.1.88%1,891,491
15EXELExelixis, Inc.1.83%3,210,913
16VRTXVertex Pharmaceuticals Incorporated1.81%311,571
17ABBVAbbVie Inc.1.78%571,989
18GILDGilead Sciences, Inc.1.78%1,050,363
19MRNAModerna, Inc.1.65%4,979,503
20CRSPCRISPR Therapeutics AG1.65%2,320,405
21BMRNBioMarin Pharmaceutical Inc.1.60%2,221,158
22ALNYAlnylam Pharmaceuticals, Inc.1.59%257,938
23NBIXNeurocrine Biosciences, Inc.1.58%856,970
24PTCTPTC Therapeutics, Inc.1.55%1,518,872
25VKTXViking Therapeutics, Inc.1.51%2,998,508
Showing 25 of 135 holdings
Subscribe to see the full list
As of Nov 18, 2025